RNAZ ▼ -5.9% - TransCode Therapeutics, Inc. $RNAZ RNAZ - TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up 28-SEP-2026 08:04 AM ET